ONSOLIS

Entity type image
Type: Product
Name: ONSOLIS
First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

BioDelivery Sciences to Present at the William Blair 33rd Annual Growth Stock Conference

/PRNewswire/ --$ BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo , President and Chief Executive Officer of BDSI, will present at the William Blair 33 rd Annual Growth Stock Conference.$ The presentation is scheduled ... [Published Barchart - Jun 05 2013]
First reported May 28 2013 - Updated May 28 2013 - 1 reports
Biodelivery Sciences International Inc
Biodelivery Sciences International Inc

BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference

/PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Jefferies 2013 Global Healthcare Conference. The presentation is scheduled for ... [Published Michigan Live - May 28 2013]

Quotes

...As a result of the feedback obtained, BDSI will continue forward with its NDA submission as planned. "We are pleased with the outcome of our pre-NDA meeting where we reviewed the key elements of our NDA with the Agency" said Dr. Andrew Finn
BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Me ... [Published Benzinga.com - Jun 10 2013]
...Some currently marketed products against which Insys directly competes include Teva Pharmaceutical Industries Ltd. "s (TEVA) Fentora and Actiq, Orexo AB's Abstral, Archimedes Pharma Ltd." s Lazanda and BioDelivery Sciences International Inc.'s (BDSI) Onsolis...
3 Healthcare Companies With Recent Intensive Insider Buying [Published Seeking Alpha - Jun 09 2013]
...com, adds that the relevant information illustrates that people continue to file Fentanyl lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”"
30 Actions Currently Pending in the Watson Fentanyl Multi-District Litigation: Now, AttorneyOne C ... [Published PRWeb - Mar 13 2013]

More Content

All (10) | News (8) | Reports (1) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
BioDelivery Sciences Announces NDA Submission f... [Published Benzinga.com - Jun 10 2013]
3 Healthcare Companies With Recent Intensive In... [Published Seeking Alpha - Jun 09 2013]
BioDelivery Sciences to Present at the William ... [Published Barchart - Jun 05 2013]
BioDelivery Sciences Primed To Grab Its Share O... [Published Trefis - May 28 2013]
BioDelivery Sciences to Present at the Jefferie... [Published Michigan Live - May 28 2013]
30 Actions Currently Pending in the Watson Fent... [Published PRWeb - Mar 13 2013]
Meda AB (publ) – Year-end report, January - Dec... [Published CisionWire - English - Feb 19 2013]
Drug Makers Get EU Complaint over Generic Fenta... [Published PRWeb - Feb 15 2013]
Fentanyl Injection Shortages Reported: Severe A... [Published PRWeb - Dec 21 2012]
Fentanyl Shortages Reported: Threat Remains [Published PRWeb - Oct 26 2012]
1
In Focus
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
Meda AB (publ) – Year-end report, January - Dec... [Published CisionWire - English - Feb 19 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.